| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Glycosaminoglycan degradation 0.91616964877403 2.375668340552491 0.017517199948559 0.99997381824321 1.0 6 P06865,P16278,P54802,P15586,P08236 5 |
| 7oxoc and 7betahc pathways 0.8889534594642917 2.304470569095636 0.0211962426008389 0.9999972120189384 1.0 9 O15118,Q15125,P61916,Q9UBM7 4 |
| Degradation pathway of sphingolipids including diseases 0.8843221743453732 2.261641957495151 0.0237195334997506 0.9999994029149476 1.0 7 P15289,P07686,P16278,P06865,P17900,P06280 6 |
| Statin inhibition of cholesterol production 0.8932046006784298 2.2267125291253898 0.0259664925299967 0.9999998491252304 1.0 5 Q8WTV0,Q07954 2 |
| Oxysterols derived from cholesterol 0.8430843076194211 2.0974872087475234 0.0359504683169138 0.999999999678404 1.0 7 Q15125,Q9UBM7 2 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8430173025899587 2.0893578682161613 0.0366755208289188 0.9999999997947704 1.0 6 Q14739,Q15125,Q15392,Q9UBM7 4 |
| Vitamin d metabolism 0.923398079971317 1.8020006408034115 0.0715453047430403 1.0 1.0 3 Q9UBM7 1 |
| Neural crest cell migration in cancer 0.767359524807347 1.7947036842161228 0.0727009232551247 1.0 1.0 8 Q99523,P61586 2 |
| Sphingolipid metabolism in senescence 0.7513015672222421 1.7437749628191348 0.0811983379173311 1.0 1.0 10 Q13510,P16278,O15269,P04062,P28482,Q06136 6 |
| Sphingolipid metabolism overview 0.7701618222499524 1.7348645324927494 0.0827648026099607 1.0 1.0 5 Q06136,Q13510,O15269 3 |
| Sphingolipid metabolism integrated pathway 0.7701618222499524 1.7348645324927494 0.0827648026099607 1.0 1.0 5 Q06136,Q13510,O15269 3 |
| Ebola virus infection in host 0.5694598379314262 1.732577444137966 0.0831708011966825 1.0 1.0 36 P04439,P10321,O15118,P09497,Q99816,P28482,P21333,P41440,Q16512,P51151,P61916,Q07021,P05556,P61586 14 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.7007096019428556 1.7267005187092408 0.084221462469292 1.0 1.0 21 Q9UBM7,P48449,Q14739,P35610,Q15392,Q15125 6 |
| Ketogenesis and ketolysis 0.7416541981935973 1.6773958358661003 0.09346510312134 1.0 1.0 6 P23786,O43772 2 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.745674820830752 1.6342794223263426 0.1022001924357762 1.0 1.0 5 P09601 1 |
| Cell migration and invasion through p75ntr 0.7436243974094542 1.6258224837730195 0.1039874239198441 1.0 1.0 5 P61586 1 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.8000246158012833 1.5945120367213443 0.1108213969576699 1.0 1.0 4 P09601 1 |
| Angiotensin ii receptor type 1 pathway 0.8662694472029144 1.5896477339205988 0.1119142310165517 1.0 1.0 3 Q06124,P28482 2 |
| Sarscov2 and covid19 pathway 0.8628387822993414 1.5768187310085704 0.1148372404258868 1.0 1.0 3 Q8WTV0 1 |
| 15q112 copy number variation syndrome 0.792260293625076 1.5645602835665564 0.1176860475541241 1.0 1.0 4 Q96CW5 1 |
| Sphingolipid pathway 0.71281447089249 1.5598323931613038 0.1187994943093178 1.0 1.0 7 Q06136,Q13510,P04062,O15269 4 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.6918172085878052 1.5432402774820655 0.1227724880959966 1.0 1.0 15 P05067,P28482,P16989,P04792 4 |
| Kallmann syndrome 0.7865179122406251 1.5423762024491956 0.1229822010408345 1.0 1.0 4 Q06124,P28482 2 |
| Metabolism of spingolipids in er and golgi apparatus 0.8520357497517379 1.5363759784713806 0.1244461947613253 1.0 1.0 3 Q06136,O95470 2 |
| Tolllike receptor signaling related to myd88 0.7843500686434546 1.5339945776236628 0.12503098676456 1.0 1.0 4 Q9H0E2,P28482 2 |
| Rala downstream regulated genes 0.705926448851127 1.5284716593525671 0.1263954748341107 1.0 1.0 6 P11233,P16989,Q96KP1 3 |
| Map3k1 role in promoting and blocking gonadal determination 0.7774282619845818 1.5072089510248046 0.1317571066243588 1.0 1.0 4 P61586 1 |
| Oxidation by cytochrome p450 0.7127799943627834 1.498036876350188 0.1341236697690011 1.0 1.0 5 O43169 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7740451608133627 1.4941047832365957 0.1351482339820144 1.0 1.0 4 P09601 1 |
| Glucocorticoid receptor pathway 0.6942023288234163 1.4792612748634042 0.1390704984843633 1.0 1.0 6 P27105 1 |
| Proteasome degradation 0.4753485533541355 1.471092672629568 0.1412660563659566 1.0 1.0 41 P28074,P04439,P10321,P28072,P28070,P49721,P49720,P60900 8 |
| Cytosine methylation 0.7048674025900049 1.4651028130777224 0.1428928693037456 1.0 1.0 5 O75874,P26358 2 |
| Gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases 0.8236893555043074 1.4299993855551294 0.1527171954248256 1.0 1.0 3 O75223 1 |
| G13 signaling pathway 0.6639066807302438 1.412728590855482 0.157735541644878 1.0 1.0 15 P61586,Q16512,Q92888,Q7L576 4 |
| Familial partial lipodystrophy fpld 0.67117732414205 1.382934438968637 0.1666849693329926 1.0 1.0 7 O60725,O75844 2 |
| Ras and bradykinin pathways in covid19 0.7429249601310777 1.3732510942840008 0.1696743005537637 1.0 1.0 4 P61586 1 |
| Familial hyperlipidemia type 3 0.9874255459960294 1.3711715548008712 0.170321483226477 1.0 1.0 2 Q8WTV0 1 |
| Influence of laminopathies on wnt signaling 0.6665042415129847 1.3684916577019703 0.171158231495766 1.0 1.0 9 O60725 1 |
| Lung fibrosis 0.6631845240024771 1.3484250411391734 0.1775217144021543 1.0 1.0 6 P15924,P09601 2 |
| Dna mismatch repair 0.6357923653268591 1.328572156280572 0.1839891632544683 1.0 1.0 18 Q9UQ84,Q9NRF9,Q9NR33 3 |
| Serine metabolism 0.6574033252254827 1.323957076938307 0.1855173004346839 1.0 1.0 6 P00374 1 |
| Neural crest cell migration during development 0.6515522818248125 1.2990295096303457 0.1939338021686216 1.0 1.0 7 P61586 1 |
| Inclusion body myositis 0.9636002647253484 1.283141061497961 0.1994426603070076 1.0 1.0 2 P05067 1 |
| Progeriaassociated lipodystrophy 0.6425311369381057 1.26365656963203 0.2063533197573592 1.0 1.0 9 O60725,O75844,O75531 3 |
| Nuclear receptors metapathway 0.4369698634852778 1.2517560864819854 0.2106587560440238 1.0 1.0 42 P23786,P48507,P09601,O14880,P27105,P08183,O00170,P11802,Q15043,Q15185,Q14914,P50416 12 |
| Il10 antiinflammatory signaling pathway 0.7094834260275841 1.2430329223588934 0.213855701840961 1.0 1.0 4 P09601 1 |
| Cannabinoid receptor signaling 0.7714939551199671 1.2337971618293768 0.2172784972868942 1.0 1.0 3 P10644 1 |
| Genes controlling nephrogenesis 0.6351982147332026 1.2298267826180784 0.2187619766193955 1.0 1.0 6 P11047,O94813 2 |
| Aryl hydrocarbon receptor pathway wp2873 0.6993848456833692 1.203712868747594 0.2287005766280136 1.0 1.0 4 O00170 1 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.7623065807478577 1.1993232706658203 0.2304022699675671 1.0 1.0 3 P28482 1 |
| Cancer immunotherapy by pd1 blockade 0.7614679080450225 1.1961785221000336 0.2316269004619018 1.0 1.0 3 P04439 1 |
| Striated muscle contraction pathway 0.6403747530603575 1.1953090271579234 0.2319663141188113 1.0 1.0 5 P67936,P06753,O43707 3 |
| Nephrotic syndrome 0.6212743713880049 1.183698616899689 0.2365323866736079 1.0 1.0 12 P11047,O75844,Q14108,P35579 4 |
| Cholesterol biosynthesis pathway 0.6214046936612676 1.1783068797542884 0.2386742860686923 1.0 1.0 11 Q16850,Q9UBM7,P48449 3 |
| Cellular proteostasis 0.6914947172408701 1.1730122673004797 0.2407908863545653 1.0 1.0 4 Q9UHV9,P61758 2 |
| Ferroptosis 0.5781624111019545 1.1474585974439988 0.2511921351547439 1.0 1.0 23 P48507,P09601,P45880,P04792,P02786,Q15365,Q15043 7 |
| Glutathione metabolism 0.6154254881566169 1.1441800152803423 0.252548989321709 1.0 1.0 7 O75874,P48507 2 |
| Supression of hmgb1 mediated inflammation by thbd 0.7463226865624597 1.1394700913388274 0.2545071360155413 1.0 1.0 3 P09429 1 |
| Physiological and pathological hypertrophy of the heart 0.6099176654885493 1.1199527562474376 0.2627338949901934 1.0 1.0 8 P61586 1 |
| Alzheimers disease 0.4514948361475747 1.0968657858344328 0.272700067146979 1.0 1.0 81 P21796,Q07954,P05067,P45880,P28072,P28070,P49721,Q92542,P28482,P49720,P60900 11 |
| Nrf2are regulation 0.6034259077955725 1.0950386763569404 0.2734996926569153 1.0 1.0 6 P09601 1 |
| Nitric oxide metabolism in cystic fibrosis 0.6158644043019864 1.0927233530292637 0.2745152831381783 1.0 1.0 5 Q86X55,O14744,O95865 3 |
| Alzheimers disease and mirna effects 0.4490496859290989 1.062994171534084 0.2877845945128841 1.0 1.0 82 P21796,Q07954,P05067,P45880,P28072,P28070,P49721,Q92542,P28482,P49720,P60900 11 |
| Disorders of folate metabolism and transport 0.5944113176415465 1.0541826716910534 0.2917992919364409 1.0 1.0 7 P00374 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.5743370617107142 1.0414891082391908 0.2976486055831697 1.0 1.0 19 O75531,P28482,Q14739,Q8NF91,P61586 5 |
| Arrhythmogenic right ventricular cardiomyopathy 0.5859469056897684 1.023398180358407 0.3061196194097126 1.0 1.0 12 P15924,P14923 2 |
| Nocgmppkg mediated neuroprotection 0.5856539406737867 1.0167646790615972 0.3092653885626362 1.0 1.0 7 Q13557,P30536,Q99996 3 |
| Base excision repair 0.5783648650693505 0.9891050429803764 0.3226117505271579 1.0 1.0 12 Q9NRF9,Q9NR33 2 |
| Regulation of actin cytoskeleton 0.4526303159056412 0.9743061738700016 0.3299045401130021 1.0 1.0 37 Q9UQB8,Q8N8S7,Q14344,P28482,Q16512,P35580,Q92888,P61586 8 |
| Alpha 6 beta 4 signaling pathway 0.5748487312181497 0.9675361240898364 0.3332760916632651 1.0 1.0 9 P11047,Q06124,P61586,P28482 4 |
| Primary focal segmental glomerulosclerosis fsgs 0.562368201705552 0.9669508735058696 0.3335685928598728 1.0 1.0 18 P11047,P35579,Q14108,P05556 4 |
| Eicosanoid synthesis 0.8749172733289239 0.9609266343513256 0.3365890577890527 1.0 1.0 2 P09960 1 |
| Fragile x syndrome 0.422548454989412 0.9584705786981218 0.3378255204250231 1.0 1.0 40 Q06124,P05067,P10644,Q9NZ01,Q7L576,P28482,P50416 7 |
| Oxidative damage response 0.6346464781008461 0.9532816486183496 0.3404473870170093 1.0 1.0 4 P60953,O95429 2 |
| Transsulfuration pathway 0.5673057464139785 0.9360533979831837 0.3492456953398002 1.0 1.0 8 P48507,P26358,Q9NZL9,P17174,P25325 5 |
| Heart development 0.6908080421157864 0.9338617359043524 0.3503752189865059 1.0 1.0 3 P28482 1 |
| Ebsteinbarr virus lmp1 signaling 0.5760845466643671 0.927430167320043 0.3537032336506436 1.0 1.0 5 P28482 1 |
| Folate metabolism 0.5606888258049894 0.919116118675832 0.3580348391819645 1.0 1.0 14 P00374,Q8WTV0 2 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.6801152945930395 0.8948905141986255 0.3708456180101738 1.0 1.0 3 P26358 1 |
| Onecarbon metabolism and related pathways 0.5553254328139114 0.8943906745169468 0.3711129002449265 1.0 1.0 14 P04818,P48507,O43865,P35790 4 |
| Hair follicle development organogenesis part 2 of 3 0.6778522744754945 0.8866777753218444 0.375252407163289 1.0 1.0 3 Q9BZE4 1 |
| Vitamin d in inflammatory diseases 0.563514963146805 0.8757733633307605 0.3811532533698467 1.0 1.0 5 O60244 1 |
| Development of ureteric collection system 0.6112509562446825 0.8642857123597171 0.3874309569544025 1.0 1.0 4 O94813 1 |
| Atm signaling in development and disease 0.5262285923786619 0.8502250771030019 0.3951999621502173 1.0 1.0 22 P04792 1 |
| 1q211 copy number variation syndrome 0.541812598653729 0.8311178748620228 0.4059070427988187 1.0 1.0 7 Q9NPH0 1 |
| Fatty acid betaoxidation 0.531014213195996 0.8262249786849128 0.4086764812140964 1.0 1.0 19 P23786,O43772 2 |
| Mitochondrial long chain fatty acid betaoxidation 0.539988156183438 0.8240451701246171 0.4099138927109749 1.0 1.0 14 P23786 1 |
| Imatinib and chronic myeloid leukemia 0.6508009122395899 0.789622488626142 0.4297482706970166 1.0 1.0 3 P08183 1 |
| Pilocytic astrocytoma 0.8153540701522184 0.7544622923222186 0.450571679333078 1.0 1.0 2 Q06124 1 |
| Nanoparticlemediated activation of receptor signaling 0.5140593772113506 0.7161055732824201 0.4739261626885716 1.0 1.0 7 P05556,P49023,P28482 3 |
| Il4 signaling pathway 0.5154689593157706 0.7131454322453307 0.4757557685711966 1.0 1.0 9 P62993,Q06124,P28482 3 |
| Nucleotidebinding oligomerization domain nod pathway 0.5065952028018894 0.6856712059193859 0.4929204681254331 1.0 1.0 7 Q7L5N1,Q9Y2Z0 2 |
| Nucleotide excision repair 0.4957035902904567 0.6785025534259188 0.4974531053858966 1.0 1.0 21 Q9NRF9,Q9NR33 2 |
| Joubert syndrome 0.505179289194563 0.6706696339599229 0.5024310115433888 1.0 1.0 15 O43924,Q15154,Q9Y4I1,P61586 4 |
| Pdgf pathway 0.5036276469565296 0.6603689155427822 0.5090171148786795 1.0 1.0 14 Q06124,P62993,P28482,Q16512,P61586 5 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5002916238084988 0.6456442310544769 0.5185097853889009 1.0 1.0 14 O60725,O75844,P55209 3 |
| Retinoblastoma gene in cancer 0.3499679467976181 0.6388552746719215 0.522917085918086 1.0 1.0 47 P04818,P26358,Q9Y619,Q14527,Q13309,O95239,P26583,P00374,P11802,P09884,P78527,P14635,P09429,Q14566 14 |
| Sterol regulatory elementbinding proteins srebp signaling 0.4732837196940344 0.6315822447009058 0.5276598916082416 1.0 1.0 25 P55735,Q8WTV0,P48449 3 |
| Erk pathway in huntingtons disease 0.7720052945069531 0.613109411714109 0.5398039974541013 1.0 1.0 2 P28482 1 |
| Corticotropinreleasing hormone signaling pathway 0.4898431111138656 0.606082435679257 0.5444600138000553 1.0 1.0 16 P42892,P14923,P61586 3 |
| Thermogenesis 0.475099581096278 0.6048525841394269 0.5452769507313602 1.0 1.0 23 P23786 1 |
| Metapathway biotransformation phase i and ii 0.480723887778266 0.6047050106000107 0.5453750182859514 1.0 1.0 21 Q86UY6,O14880,P34913,Q16850,Q7LGA3 5 |
| Fluoropyrimidine activity 0.4876423373261199 0.5916059731247811 0.5541144731228158 1.0 1.0 11 Q92820,P00374 2 |
| Spinal cord injury 0.4812049322603935 0.5783204355954766 0.5630477999812136 1.0 1.0 18 P27695,P17931,P28482,O94813,P11802,P14174,P61586 7 |
| Endothelin pathways 0.4825278307697594 0.5777900882206622 0.5634058479300286 1.0 1.0 9 P42892 1 |
| Hijack of ubiquitination by sarscov2 0.4731610337972113 0.5605410337621961 0.5751104590430463 1.0 1.0 6 Q8TBC4,Q13564,Q15369,Q15370,Q9C0D3 5 |
| Eicosanoid metabolism via lipooxygenases lox 0.4719542093718433 0.5559165004852986 0.5782679376770938 1.0 1.0 6 O15254,Q14914,P09960 3 |
| Hippo signaling regulation pathways 0.4697931155645963 0.5141812635373487 0.607125266090951 1.0 1.0 14 P10644 1 |
| Relationship between inflammation cox2 and egfr 0.5107684521133534 0.5048198969438379 0.6136853395869935 1.0 1.0 4 P28482 1 |
| Follicle stimulating hormone fsh signaling pathway 0.4683050799166283 0.5046587511747497 0.6137985374296004 1.0 1.0 5 P28482 1 |
| Transsulfuration and onecarbon metabolism 0.4578589475384482 0.4787646368390572 0.6321060768781781 1.0 1.0 19 P04818,P48507,P26358,O43865,P00374 5 |
| Physicochemical features and toxicityassociated pathways 0.4500106890087875 0.432310991703685 0.6655153994495158 1.0 1.0 15 P62993,P28482,Q16512,P61586,P35080 5 |
| Hippomerlin signaling dysregulation 0.4495259350340789 0.4311263627064326 0.6663764928810838 1.0 1.0 16 P10644,Q16512,P05556 3 |
| Congenital generalized lipodystrophy cgl 0.7035076108537439 0.4128150313743032 0.6797421377120463 1.0 1.0 2 P62993 1 |
| Mirna biogenesis 0.5263157894736894 0.3886503355299037 0.6975348259713043 1.0 1.0 3 P62826,Q9HAV4 2 |
| Chromosomal and microsatellite instability in colorectal cancer 0.4375753121567012 0.3833920402324279 0.7014291042758947 1.0 1.0 14 P11233,Q96KP1,P61586,P28482 4 |
| G protein signaling pathways 0.4374813783684928 0.3828640137078698 0.7018205949183098 1.0 1.0 17 P10644,Q14344,O43823,Q92888,P61586 5 |
| Allograft rejection 0.4302829660625995 0.3786028535888473 0.7049828027935767 1.0 1.0 9 P04439,P10321 2 |
| Type i interferon induction and signaling during sarscov2 infection 0.5196954650777965 0.3704827787795579 0.71102280569286 1.0 1.0 3 P42224,Q7Z434 2 |
| Tgfbeta signaling pathway 0.3943827487293423 0.366509898963168 0.7139846274259865 1.0 1.0 32 Q9NWH9,P05067,O14964,P62993,P28482,P63208,P05556,P61586 8 |
| Omega3 omega6 fatty acid synthesis 0.4187948149491911 0.3638838237142273 0.7159447645957846 1.0 1.0 6 O15254 1 |
| Onecarbon metabolism 0.4317803485232225 0.3636480434330416 0.7161208459587112 1.0 1.0 13 P04818,P00374 2 |
| Dna replication 0.4087120793898047 0.3525201659456389 0.7244481976508841 1.0 1.0 28 Q9Y619,Q14566 2 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.4194439119611381 0.3393253869988968 0.734364619886847 1.0 1.0 5 P05556,Q13418 2 |
| Vitamin dsensitive calcium signaling in depression 0.4091078556022456 0.3318747590664077 0.7399838305657016 1.0 1.0 6 Q8NB78,P20020 2 |
| Wnt signaling pathway 0.4205976319520802 0.3316217428636772 0.7401748993944481 1.0 1.0 11 P61586 1 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.4159987362516373 0.3287370001526429 0.7423544851625161 1.0 1.0 9 Q15126,P35610 2 |
| 3q29 copy number variation syndrome 0.4193318136067359 0.3271497625931009 0.7435546155945805 1.0 1.0 11 P02786 1 |
| Cysteine and methionine catabolism 0.4095150948663295 0.3236991932232178 0.7461657817138758 1.0 1.0 7 P17174,P25325,P48637 3 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.5000016498116073 0.3189732999999761 0.7497467595661214 1.0 1.0 3 Q9BXK5 1 |
| Mevalonate pathway 0.4494756429597417 0.3189711858772393 0.7497483627265458 1.0 1.0 4 Q15126 1 |
| Il18 signaling pathway 0.3155724813242538 0.3078228220753297 0.7582171547417493 1.0 1.0 50 Q9UMR5,P09601,Q9HC07,P35613,P28482,P04792 6 |
| Ras signaling 0.4000077536086437 0.2932037631747693 0.7693664078375089 1.0 1.0 27 P11233,Q9NWH9,Q06124,Q9Y6K9,P62993,P28482,Q16512,Q96KP1,P61586 9 |
| Hepatocyte growth factor receptor signaling 0.4103031110521435 0.2901993754555423 0.771663713979116 1.0 1.0 12 Q06124,P28482,P62993,Q16512,P49023,P05556 6 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.3953562823699182 0.2785984029436761 0.7805530384672901 1.0 1.0 7 Q16512 1 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.4779079781882209 0.2660455169203631 0.7902041543567182 1.0 1.0 3 P28482 1 |
| Ectoderm differentiation 0.4072353400565147 0.2641662948223723 0.7916517816308135 1.0 1.0 17 P16278,P14923,P35237 3 |
| Dna repair pathways full network 0.3006727991018627 0.25832962762234 0.7961525225196087 1.0 1.0 44 Q9UQ84,P41440,Q9NRF9,Q9NR33 4 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.3962481401936502 0.2430164100586339 0.8079926850673653 1.0 1.0 12 Q9UHD1,Q16512,P11802,P62993 4 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.3865854141466282 0.2427219643853627 0.8082207910684414 1.0 1.0 8 P31943,P20339,O14964,P28482 4 |
| Microtubule cytoskeleton regulation 0.3990033222591495 0.2422143999356017 0.8086140376798558 1.0 1.0 14 Q16555,O60610,P06493,Q7KZI7,Q15691,P16949,P40763,Q16512,P46821,P60953,Q99661,Q13464,Q9Y281 13 |
| Rac1pak1p38mmp2 pathway 0.3977394997577912 0.2342230686053305 0.8148118069071133 1.0 1.0 15 Q06124,P62993,P28482,Q16512,P49023,P05556 6 |
| Sudden infant death syndrome sids susceptibility pathways 0.3938444499614713 0.233245785007345 0.8155705548284742 1.0 1.0 24 P10644,P42892 2 |
| Gastrin signaling pathway 0.3942809254146388 0.2232919024773659 0.8233083290712777 1.0 1.0 22 Q06124,P62993,P28482,Q16512,P49023,P62753,P05556,P61586 8 |
| Sars coronavirus and innate immunity 0.6118464592984851 0.2076101282188544 0.8355333955001552 1.0 1.0 2 Q7Z434 1 |
| Il17 signaling pathway 0.4033453998591536 0.2057696848592974 0.8369708224176509 1.0 1.0 4 P28482 1 |
| Kennedy pathway from sphingolipids 0.4459958176261547 0.1994887126919631 0.8418804718825905 1.0 1.0 3 P35790 1 |
| Epithelial to mesenchymal transition in colorectal cancer 0.3872794353700287 0.1908579607156912 0.8486368771443447 1.0 1.0 19 P15924,P14923,P28482 3 |
| Serotonin and anxiety 0.6002647253474598 0.1878029937065259 0.8510310888888648 1.0 1.0 2 Q08209 1 |
| Serotonin htr1 group and fos pathway 0.3690442214282171 0.1835602948121109 0.8543584139130329 1.0 1.0 9 P61586 1 |
| Resistin as a regulator of inflammation 0.3572627636318588 0.1812456592677017 0.856174757117304 1.0 1.0 6 P31751,Q9Y6K9,P28482 3 |
| Netrinunc5b signaling pathway 0.3736783225158543 0.1734513166729088 0.8622966914543482 1.0 1.0 12 Q06124,P61586,P28482 3 |
| Nrf2 pathway 0.3806072989716934 0.1708510667532239 0.8643408738866307 1.0 1.0 17 Q15043,Q14914,P48507,P09601 4 |
| Interleukin11 signaling pathway 0.3689479113718951 0.1599189556004635 0.8729449162807064 1.0 1.0 12 P62753,Q06124,P28482 3 |
| Disruption of postsynaptic signaling by cnv 0.3584858215345649 0.1554836614086726 0.876440033605342 1.0 1.0 9 Q13557,Q7L576,P28482 3 |
| Fas ligand pathway and stress induction of heat shock proteins 0.3705841652498921 0.1521850651049219 0.8790409730757685 1.0 1.0 14 Q16512,P04792 2 |
| Il5 signaling pathway 0.3619523035236894 0.1480124206878964 0.8823329659212837 1.0 1.0 11 P62753,Q06124,P28482 3 |
| Camkk2 pathway 0.3529635302881649 0.1415345901821419 0.8874476360555665 1.0 1.0 9 P09601 1 |
| T cell receptor and costimulatory signaling 0.3675496688741633 0.1370871550946155 0.8909619053612527 1.0 1.0 4 Q08209,P48729,P19174 3 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.4008606421714595 0.1265947580436589 0.8992611460354454 1.0 1.0 3 P31751,Q9P2K5 2 |
| Small cell lung cancer 0.3534287600467969 0.1258757422022985 0.8998302848387632 1.0 1.0 11 P11047,P63208,P05556,P11802 4 |
| Rett syndrome causing genes 0.3613660020062544 0.1203519055590663 0.9042043881937212 1.0 1.0 15 Q9UPW6 1 |
| Interactome of polycomb repressive complex 2 prc2 0.3269294468367102 0.1102672002544732 0.912197469010005 1.0 1.0 5 Q9Y2W1,O75530,Q15022,Q09028 4 |
| Aryl hydrocarbon receptor pathway wp2586 0.3349929054584101 0.1090654032231415 0.9131506153802094 1.0 1.0 8 P28482 1 |
| Wnt signaling 0.3487849221579168 0.0993827846781697 0.9208343509259204 1.0 1.0 13 P61586 1 |
| Prolactin signaling pathway 0.3599284503638055 0.0987233488503467 0.9213579297223808 1.0 1.0 20 Q06124,P62993,P28482,Q16512,P49023,P62753,P05556 7 |
| Mitochondrial complex iii assembly 0.3363796877694445 0.0939181046222811 0.925174211996346 1.0 1.0 10 Q6DKK2,P31930,O14949 3 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.3355646527108977 0.0921303216038404 0.926594497738543 1.0 1.0 10 P62753,P28482 2 |
| Estrogen signaling pathway 0.3094932776487308 0.082098248587485 0.9345685858490552 1.0 1.0 5 P28482 1 |
| Mesodermal commitment pathway 0.3541059721398826 0.0809749596201994 0.9354618664239388 1.0 1.0 20 P10644,Q8N3C0 2 |
| G1 to s cell cycle control 0.3514540795941805 0.0720585566290605 0.9425553074658736 1.0 1.0 24 Q13416,Q9Y619,P11802,Q14566 4 |
| Met in type 1 papillary renal cell carcinoma 0.3488361641693708 0.0683455432022264 0.9455105706272644 1.0 1.0 19 Q9NWH9,Q06124,P62993,P28482,O43815,Q16512,Q14241 7 |
| Hif1a and pparg regulation of glycolysis 0.3350612298447574 0.0632504883758376 0.9495670413213252 1.0 1.0 3 P04406 1 |
| Genes related to primary cilium development based on crispr 0.3233144587545042 0.0581223688090932 0.9536511567769907 1.0 1.0 11 Q9Y496,O95684 2 |
| Egfr tyrosine kinase inhibitor resistance 0.3293603898517137 0.0545649896545848 0.9564850313938668 1.0 1.0 13 O60573,P62753,P62993,P28482 4 |
| Il1 signaling pathway 0.3270106720646868 0.0496339216651244 0.9604141143558218 1.0 1.0 13 Q9H0E2,P28482 2 |
| Estrogen receptor pathway 0.2989076464746726 0.0460393527002679 0.9632788842299138 1.0 1.0 3 Q15067,P40763 2 |
| Agerage pathway 0.334295368202737 0.0452684328331616 0.9638933485832636 1.0 1.0 16 P17931,P61586,P28482 3 |
| Dna damage response only atm dependent 0.3306586142872116 0.0432975675571967 0.9654643302139764 1.0 1.0 15 P61586,P62993,P09429,P28482 4 |
| Benzoapyrene metabolism 0.3785572468563957 0.0362586872125754 0.9710760910907884 1.0 1.0 2 P07099 1 |
| Osteoblast differentiation and related diseases 0.2910732830639169 0.03090356305104 0.9753464483779836 1.0 1.0 8 P28482 1 |
| Hostpathogen interaction of human coronaviruses autophagy 0.2460264900662163 0.0260708855663742 0.9792007991186832 1.0 1.0 4 Q99570,Q9NT62,O95352 3 |
| Adipogenesis 0.3184270271400664 0.0110960372174026 0.9911468248886794 1.0 1.0 16 Q9NZ45,O75844,P43490,P14174 4 |
| Integrinmediated cell adhesion 0.3265929697322612 0.003482137894118 0.9972216615503884 1.0 1.0 21 P62993,P28482,P07384,Q16512,P49023,P05556 6 |
| Focal adhesion 0.3197176457458262 0.0033335791242164 0.9973401936108676 1.0 1.0 32 Q9NWH9,P11047,P62993,P21333,P28482,Q16512,P49023,P05556,P61586 9 |
| Acute viral myocarditis 0.2954214973765005 0.0018158246932007 0.9985511823083488 1.0 1.0 12 P28482 1 |
|
|
